Pubblicazioni

In questa sezione viene presentata una selezione della produzione scientifica del gruppo di ricerca, in particolare le comunicazioni scientifiche e gli articoli pubblicati dal 2004 su riviste nazionali ed internazionali che hanno Impact Factor.
 

Totale pubblicazioni a partire dal 2011: 205


Anno

2019; (): e728

Association of a homozygous GCK missense mutation with mild diabetes.

Marucci A, Biagini T, Di Paola R, Menzaghi C, Fini G, Castellana S, Cardinale GM, Mazza T, Trischitta V


2018; 62(1): 215-233

Multiple endocrine neoplasia type 1: analysis of germline MEN1 mutations in the Italian multicenter MEN1 patient database.

Marini F, Giusti F, Fossi C, Cioppi F, Cianferotti L, Masi L, Boaretto F, Zovato S, Cetani F, Colao A, Davì MV, Faggiano A, Fanciulli G, Ferolla P, Ferone D, Loli P, Mantero F, Marcocci C, Opocher G, Beck-Peccoz P, Persani L, Scillitani A, Guizzardi F, S


2018; 41(11): 1339-1348

Clinical presentation and management of patients with primary hyperparathyroidism in Italy.

Saponaro F, Cetani F, Repaci A, Pagotto U, Cipriani C, Pepe J, Minisola S, Cipri C, Vescini F, Scillitani A, Salcuni A, Palmieri S, Eller-Vainicher C, Chiodini I, Madeo B, Kara E, Castellano E, Borretta G, Gianotti L, Romanelli F, Camozzi V, Faggiano A, C


2018; ():

Bone involvement and mineral metabolism in Williams' syndrome.

Palmieri S, Bedeschi MF, Cairoli E, Morelli V, Lunati ME, Scillitani A, Carnevale V, Lalatta F, Barbieri AM, Orsi E, Spada A, Chiodini I, Eller-Vainicher C


2018; 10(5):

Italian Association of Clinical Endocrinologists (AME) and Italian Chapter of the American Association of Clinical Endocrinologists (AACE) Position Statement: Clinical Management of Vitamin D Deficiency in Adults.

Cesareo R, Attanasio R, Caputo M, Castello R, Chiodini I, Falchetti A, Guglielmi R, Papini E, Santonati A, Scillitani A, Toscano V, Triggiani V, Vescini F, Zini M, AME and Italian AACE Chapter.


2018; 66(3): 518-524

Protective Effect of Denosumab on Bone in Older Women with Primary Hyperparathyroidism.

Eller-Vainicher C, Palmieri S, Cairoli E, Goggi G, Scillitani A, Arosio M, Falchetti A, Chiodini I


2018; 32(6): 877-889

Parathyroid carcinoma.

Salcuni AS, Cetani F, Guarnieri V, Nicastro V, Romagnoli E, de Martino D, Scillitani A, Cole DEC


2018; 28(6): 643-644

BMI correlates with pulse pressure in offspring of patients with type 2 diabetes and albuminuria.

Bacci S, di Lorenzo A, Greco EV, Tinti MG, Rauseo A, Palena AP, Vendemiale G, De Cosmo SBacci S, di Lorenzo A, Greco EV, Tinti MG, Rauseo A, Palena AP, Vendemiale G, De Cosmo S, Bacci S, di Lorenzo A, Greco EV, Tinti MG, Rauseo A, Palena AP, Vendemiale G,


2018; 19(9): 793-796

Assessment of Skeletal Muscle Mass in Older People: Comparison Between 2 Anthropometry-Based Methods and Dual-Energy X-ray Absorptiometry.

Carnevale V, Castriotta V, Piscitelli PA, Nieddu L, Mattera M, Guglielmi G, Scillitani A


2018; 122(5): 910

Is There Really a Paradoxical Effect of Obesity on Mortality Rate in High-Risk Patients? It Is Time for Large Mendelian Randomization Studies.

Trischitta V, Di Paola R


2018; ():

Circulating adiponectin levels are paradoxically associated with mortality rate. A systematic review and meta-analysis.

Scarale MG, Fontana A, Trischitta V, Copetti M, Menzaghi C


2018; ():

Molecular pathogenesis of parathyroid tumours.

Cinque L, Pugliese F, Salcuni AS, Scillitani A, Guarnieri V


2018; 25(7): 761-771

The aberrantly expressed miR-372 partly impairs sensitivity to apoptosis in parathyroid tumor cells.

Verdelli C, Forno I, Morotti A, Creo P, Guarnieri V, Scillitani A, Cetani F, Vicentini L, Balza G, Beretta E, Ferrero S, Vaira V, Corbetta S


2018; ():

Can HbA1c combined with fasting plasma glucose help to assess priority for GCK-MODY vs HNF1A-MODY genetic testing?

Delvecchio M, Salzano G, Bonura C, Cauvin V, Cherubini V, d'Annunzio G, Franzese A, Giglio S, Grasso V, Graziani V, Iafusco D, Iughetti L, Lera R, Maffeis C, Maltoni G, Mantovani V, Menzaghi C, Patera PI, Rabbone I, Reindstadler P, Scelfo S, Tinto N, Toni


2018; 9(29): 20721-20733

Large deletion at the CDC73 gene locus and search for predictive markers of the presence of a CDC73 genetic lesion.

Muscarella LA, Turchetti D, Fontana A, Baorda F, Palumbo O, la Torre A, de Martino D, Franco R, Losito NS, Repaci A, Pagotto U, Cinque L, Copetti M, Chiofalo MG, Pezzullo L, Graziano P, Scillitani A, Guarnieri V


2018; 25(3): L7-L11

8th edition of the AJCC/TNM staging system of thyroid cancer: what to expect (ITCO#2).

Lamartina L, Grani G, Arvat E, Nervo A, Zatelli MC, Rossi R, Puxeddu E, Morelli S, Torlontano M, Massa M, Bellantone R, Pontecorvi A, Montesano T, Pagano L, Daniele L, Fugazzola L, Ceresini G, Bruno R, Rossetto R, Tumino S, Centanni M, Meringolo D, Castag


2018; 67(1): 12-22

The Adiponectin Paradox for All-Cause and Cardiovascular Mortality.

Menzaghi C, Trischitta V


2017; 31(6): 952-957

Silent coronary heart disease in patients with type 2 diabetes: application of a screening approach in a follow-up study.

Vigili de Kreutzenberg S, Solini A, Vitolo E, Boi A, Bacci S, Cocozza S, Nappo R, Rivellese A, Avogaro A, Baroni MG


2017; ():

Long lasting prophylaxis of iodine deficiency after a successful information campaign for iodized salt consumption.

Meringolo D, Bianchi D, Bellanova B, Torlontano M, Costante G


2017; 27(11): 1378-1384

Temporal Changes in Thyroid Nodule Volume: Lack of Effect on Paranodular Thyroid Tissue Volume.

Grani G, Bruno R, Lucisano G, Costante G, Meringolo D, Puxeddu E, Torlontano M, Tumino S, Attard M, Lamartina L, Nicolucci A, Cooper DS, Filetti S, Durante C


2017; 27(12): 1490-1497

Are Evidence-Based Guidelines Reflected in Clinical Practice? An Analysis of Prospectively Collected Data of the Italian Thyroid Cancer Observatory.

Lamartina L, Durante C, Lucisano G, Grani G, Bellantone R, Lombardi CP, Pontecorvi A, Arvat E, Felicetti F, Zatelli MC, Rossi R, Puxeddu E, Morelli S, Torlontano M, Crocetti U, Montesano T, Giubbini R, Orlandi F, Aimaretti G, Monzani F, Attard M, Francese


2017; ():

Familial diabetes of adulthood: A bin of ignorance that needs to be addressed.

Prudente S, Ludovico O, Trischitta V


2017; ():

MEN1 gene mutation with parathyroid carcinoma: first report of a familial case.

Cinque L, Sparaneo A, Salcuni AS, De Martino DG, Battista C, Logoluso F, Palumbo O, Cocchi R, Maiello E, Graziano P, Hendy G, Cole DEC, Scillitani A, Guarnieri V


2017; ():

Insights from Molecular Characterization of Adult Patients of Families with Multigenerational Diabetes Mellitus.

Pezzilli S, Ludovico O, Biagini T, Mercuri L, Alberico F, Lauricella E, Dallali H, Capocefalo D, Carella M, Miccinilli E, Piscitelli P, Scarale MG, Mazza T, Trischitta V, Prudente S


2017; ():

Is the hypothalamic-pituitary-adrenal axis disrupted in type 2 diabetes mellitus and is this relevant for bone health?

Eller-Vainicher C, Scillitani A, Chiodini I


2017; 43(): 77-82

Occurrence of malignant neoplasia in patients with primary hyperparathyroidism.

Palmieri S, Roggero L, Cairoli E, Morelli V, Scillitani A, Chiodini I, Eller-Vainicher C


2017; ():

Multiple endocrine neoplasia syndrome type 1: institution, management, and data analysis of a nationwide multicenter patient database.

Giusti F, Cianferotti L, Boaretto F, Cetani F, Cioppi F, Colao A, Davì MV, Faggiano A, Fanciulli G, Ferolla P, Ferone D, Fossi C, Giudici F, Gronchi G, Loli P, Mantero F, Marcocci C, Marini F, Masi L, Opocher G, Beck-Peccoz P, Persani L, Scillitani A, Sc


2017; ():

Incidence and all-cause mortality for hip fracture in comparison to stroke, and myocardial infarction: a fifteen years population-based longitudinal study.

Carnevale V, Fontana A, Scillitani A, Sinisi R, Romagnoli E, Copetti M


2017; 60(S1): 513-514

Combined effect of high sensitive C-reactive protein and serum amyloid component P on mortality rate in patients with type 2 diabetes

Menzaghi C., Scarale M.G., Salvemini L., Copetti M., Trischitta V.

2017; 66(S1): a434

Combined Effect of High Sensitive C-Reactive Protein (hs-CRP) and Serum Amyloid Component P (SAP) on Mortality Rate in Type 2 Diabetes

Menzaghi C., Scarale M.G., Salvemini L., Copetti M., Trischitta V.

2017; 37(5): e55-e56

Letter by Menzaghi et al Regarding Article, "Plasma Levels of Fatty Acid-Binding Protein 4, Retinol-Binding Protein 4, High-Molecular-Weight Adiponectin, and Cardiovascular Mortality Among Men With Type 2 Diabetes: A 22-Year Prospective Study".

Menzaghi C, Copetti M, Trischitta V


2017; 27(4): 281-282

GALNT2 effect on HDL-cholesterol and triglycerides levels in humans: Evidence of pleiotropy?

Di Paola R, Marucci A, Trischitta V


2017; ():

PRIMARY ALDOSTERONISM AS A CAUSE OF SECONDARY OSTEOPOROSIS.

Salcuni AS, Carnevale V, Battista C, Palmieri S, Eller-Vainicher C, Guarnieri V, Pugliese F, Guglielmi G, Desina G, Minisola S, Chiodini I, Scillitani A


2017; 6(): CD010137

Glucose targets for preventing diabetic kidney disease and its progression.

Ruospo M, Saglimbene VM, Palmer SC, De Cosmo S, Pacilli A, Lamacchia O, Cignarelli M, Fioretto P, Vecchio M, Craig JC, Strippoli GF


2017; ():

Variability in HbA1c, blood pressure, lipid parameters and serum uric acid, and risk of development of chronic kidney disease in type 2 diabetes.

Ceriello A, De Cosmo S, Rossi MC, Lucisano G, Genovese S, Pontremoli R, Fioretto P, Giorda C, Pacilli A, Viazzi F, Russo G, Nicolucci A, AMD-Annals Study Group.


2017; 66(S1): A48 182 OR

Expanding the knowledge on the spectrum of familial diabetes in adult patients

Pezzilli S., Ludovico O., Biagini T., Mercuri L., Alberico F., Lauricella E., Dallali H., Basile G., Miccinilli E., Piscitelli P., De Cosmo S., Carella M., Mazza T., Trischitta V., Prudente S.

2017; ():

Expression, function, and regulation of the embryonic transcription factor TBX1 in parathyroid tumors.

Verdelli C, Avagliano L, Guarnieri V, Cetani F, Ferrero S, Vicentini L, Beretta E, Scillitani A, Creo P, Bulfamante GP, Vaira V, Corbetta S


2017; 18(1): 83

Large intragenic deletion of CDC73 (exons 4-10) in a three-generation hyperparathyroidism-jaw tumor (HPT-JT) syndrome family.

Guarnieri V, Seaberg RM, Kelly C, Jean Davidson M, Raphael S, Shuen AY, Baorda F, Palumbo O, Scillitani A, Hendy GN, Cole DEC


2017; 66(8): 2069-2071

Some Doubts About the Mantra on the Deleterious Cardiovascular Effects of Sulfonylureas.

Trischitta V, Prudente S


2017; ():

Pharmacogenetics of oral antidiabetes drugs: evidence for diverse signals at the IRS1 locus.

Prudente S, Di Paola R, Pezzilli S, Garofolo M, Lamacchia O, Filardi T, Mannino GC, Mercuri L, Alberico F, Scarale MG, Sesti G, Morano S, Penno G, Cignarelli M, Copetti M, Trischitta V


2017; 14(1): 23-30

Novel association of MEN1 gene mutations with parathyroid carcinoma.

Cinque L, Sparaneo A, Cetani F, Coco M, Clemente C, Chetta M, Balsamo T, Battista C, Sanpaolo E, Pardi E, D'Agruma L, Marcocci C, Maiello E, Hendy GN, Cole DEC, Scillitani A, Guarnieri V


2017; 33(4):

Epidemiology of diabetic kidney disease in adult patients with type 1 diabetes in Italy: The AMD-Annals initiative.

Pacilli A, Viazzi F, Fioretto P, Giorda C, Ceriello A, Genovese S, Russo G, Guida P, Pontremoli R, De Cosmo S, AMD-Annals Study Group.


2017; 7(): 44337

Suggestive evidence of a multi-cytokine resistin pathway in humans and its role on cardiovascular events in high-risk individuals.

Menzaghi C, Marucci A, Antonucci A, De Bonis C, Ortega Moreno L, Salvemini L, Copetti M, Trischitta V, Di Paola R


2017; 260(): 20-26

On the non-linear association between serum uric acid levels and all-cause mortality rate in patients with type 2 diabetes mellitus.

Lamacchia O, Fontana A, Pacilli A, Copetti M, Fariello S, Garofolo M, Penno G, Trischitta V, De Cosmo S, Cignarelli M


2017; 7(1): 61

Serum resistin is causally related to mortality risk in patients with type 2 diabetes: preliminary evidences from genetic data.

Fontana A, Ortega Moreno L, Lamacchia O, De Bonis C, Salvemini L, De Cosmo S, Cignarelli M, Copetti M, Trischitta V, Menzaghi C


2016; 53(6): 1045-1048

Urinary albumin excretion correlates with carotid intima-media thickness in offspring of patients with type 2 diabetes and albuminuria.

Bacci S, Gargano A, di Lorenzo A, De Matthaeis A, Piscitelli P, Pacilli A, Vendemiale G, De Cosmo S


2016; 7(5): 5538-47

Somatostatin analogues according to Ki67 index in neuroendocrine tumours: an observational retrospective-prospective analysis from real life.

Faggiano A, Carratù AC, Guadagno E, Tafuto S, Tatangelo F, Riccardi F, Mocerino C, Palmieri G, Damiano V, Siciliano R, Leo S, Mauro A, Tozzi LF, Battista C, De Rosa G, Colao A


2016; 34(2): 247-53

The Italian Observational Study on Severe Osteoporosis (ISSO): 24-month results on incidence of fractures and adherence to treatment.

Idolazzi L, Maugeri D, Monti S, Massarotti M, Osella G, Barbagallo M, Del Fiacco R, Silvestri S, ISSO Study Group.


2016; 101(7): 2768-75

Prediction of Vertebral Fractures in Patients With Monolateral Adrenal Incidentalomas.

Morelli V, Eller-Vainicher C, Palmieri S, Cairoli E, Salcuni AS, Scillitani A, Carnevale V, Corbetta S, Arosio M, Della Casa S, Muscogiuri G, Spada A, Chiodini I


2016; 101(2): L17-8

Letter to the Editor: Comments on "Are biochemical markers of bone turnover representative of bone histomorphometry in 370 postmenopausal women?" by Chavassieux P, Portero-Muzy N, Roux JP, Garnero P, Chapurlat R.

Carnevale V, Romagnoli E, Frusciante V, Scillitani A


2016; ():

Follow-up of patients with adrenal incidentaloma, in accordance with the European society of endocrinology guidelines: Could we be safe?

Morelli V, Scillitani A, Arosio M, Chiodini I


2016; 4(8): 641-3

Explaining geographical variation in the presentation of primary hyperparathyroidism.

Minisola S, Pepe J, Scillitani A, Cipriani C


2016; 39(7): 807-34

Italian association of clinical endocrinologists (AME) position statement: drug therapy of osteoporosis.

Vescini F, Attanasio R, Balestrieri A, Bandeira F, Bonadonna S, Camozzi V, Cassibba S, Cesareo R, Chiodini I, Francucci CM, Gianotti L, Grimaldi F, Guglielmi R, Madeo B, Marcocci C, Palermo A, Scillitani A, Vignali E, Rochira V, Zini M


2016; :

Clinical worthlessness of genetic prediction of common forms of diabetes mellitus and related chronic complications. A position Statement of the Italian Society of Diabetology

Buzzetti R., Prudente S., Copetti M., Dauriz M., Zampetti S., Garofolo M., Penno G., Trischitta V.

2016; 39(12): 2278-2287

Plasma Triglycerides and HDL-C Levels Predict the Development of Diabetic Kidney Disease in Subjects With Type 2 Diabetes: The AMD Annals Initiative.

Russo GT, De Cosmo S, Viazzi F, Pacilli A, Ceriello A, Genovese S, Guida P, Giorda C, Cucinotta D, Pontremoli R, Fioretto P, AMD-Annals Study Group.


2016; 59 (suppl 1): S512

Role of the "resistin pathway" on cardiovascular risk factors and major cardiovascular events

Menzaghi C., Marucci A., Antonucci A., De Bonis C., Ortega Moreno L., Salvemini L., Copetti M., Trischitta V., Di Paola R.

2016; 59 (suppl1): S138-139

The combined effect of adiponectin and resistin on all-cause mortality in patients with type 2 diabetes: evidence of synergism with abdominal adiposity

Ortega Moreno L., Lamacchia O., Fontana A., Copetti M., Salvemini L., De Bonis C., Cignarelli M., Trischitta V., Menzaghi C.

2016; ():

Filamin A is reduced and contributes to the CASR sensitivity in human parathyroid tumors.

Mingione A, Verdelli C, Ferrero S, Vaira V, Guarnieri V, Scillitani A, Vicentini L, Balza G, Beretta E, Terranegra A, Vezzoli G, Soldati L, Corbetta S


2016; 59(Suppl1): S1-S581

UMOD locus and glomerular filtration rate in individuals with type 2 diabetes: evidence of heterogeneity across two different European populations

Prudente S., Di Paola R., Copetti M., Lucchesi D., Lamacchia O., Pezzilli S., Mercuri L., Alberico F., GIusti L., Garofalo M., Penno G., Cignarelli M., De Cosmo S., Trischitta V.

2016; ():

MECHANISMS IN ENDOCRINOLOGY: Endogenous subclinical hypercortisolism and bone: a clinical review.

Chiodini I, Eller-Vainicher C, Morelli V, Palmieri S, Cairoli E, Salcuni AS, Copetti M, Scillitani A


2016; 53(4): 673-5

Patient/disease features and glycemic targets in type 2 diabetes: Where do we stand?

Pacilli A, Fallarino M, Massa M, Filardi T, De Cosmo S, Morano S, Trischitta V


2016; ():

The rs12917707 polymorphism at the UMOD locus and glomerular filtration rate in individuals with type 2 diabetes: evidence of heterogeneity across two different European populations.

Prudente S, Di Paola R, Copetti M, Lucchesi D, Lamacchia O, Pezzilli S, Mercuri L, Alberico F, Giusti L, Garofolo M, Penno G, Cignarelli M, De Cosmo S, Trischitta V


2016; ():

Vitamin D status in primary hyperparathyroidism: effect of genetic background.

Battista C, Guarnieri V, Carnevale V, Baorda F, Pileri M, Garrubba M, Salcuni AS, Chiodini I, Minisola S, Romagnoli E, Eller-Vainicher C, Santini SA, Parisi S, Frusciante V, Fontana A, Copetti M, Hendy GN, Scillitani A, Cole DE


Il Diabete, Supp.I, 2016, P192 2016; : 93

Ruolo del polimorfismo rs12917707 nel gene UMOD nella modulazione del GFR in pazienti italiani con diabete di tipo 2

Pezzilli S., Di Paola R., Copetti M., Lucchesi D., La Macchia O., Mercuri L., Alberico F., Pucci L., Penno G., Cignarelli M., De Cosmo S., Trischitta V., Prudente S.

Il Diabete, Supp.I, 2016, P121 2016; : 75

Polimorfismo P12A di PPARg2 e mortalità per tutte le cause in pazienti con diabete mellito di tipo 2

Pacilli A., Prudente S., Copetti M., Fontana A., Bacci S., Marucci A., La Macchia O., Cignarelli M., De Cosmo S., Trischitta V.

2016; 250(): 23-29

The combined effect of adiponectin and resistin on all-cause mortality in patients with type 2 diabetes: Evidence of synergism with abdominal adiposity.

Ortega Moreno L, Lamacchia O, Fontana A, Copetti M, Salvemini L, De Bonis C, Cignarelli M, Trischitta V, Menzaghi C


2016; 26(2): 103-8

The "Sapienza University Mortality and Morbidity Event Rate (SUMMER) study in diabetes": Study protocol.

Barchetta I, Capoccia D, Baroni MG, Buzzetti R, Cavallo MG, De Cosmo S, Leonetti F, Leotta S, Morano S, Morviducci L, Prudente S, Pugliese G, Trischitta V, SUMMER Study in Diabetes Group


2016; ():

The PPAR?2 P12A polymorphism is not associated with all-cause mortality in patients with type 2 diabetes mellitus.

Pacilli A, Prudente S, Copetti M, Fontana A, Mercuri L, Bacci S, Marucci A, Alberico F, Viti R, Palena A, Lamacchia O, Cignarelli M, De Cosmo S, Trischitta V


2016; ():

EZH2 and ZFX oncogenes in malignant behaviour of parathyroid neoplasms.

Sanpaolo E, Miroballo M, Corbetta S, Verdelli C, Baorda F, Balsamo T, Graziano P, Fabrizio FP, Cinque L, Scillitani A, Muscarella LA, Guarnieri V


2016; 15(1): 17

Evidence of a causal relationship between high serum adiponectin levels and increased cardiovascular mortality rate in patients with type 2 diabetes.

Ortega Moreno L, Copetti M, Fontana A, De Bonis C, Salvemini L, Trischitta V, Menzaghi C


2016; 245(): 222-227

The paradoxical association of adiponectin with mortality rate in patients with type 2 diabetes: evidence of synergism with kidney function.

Ortega Moreno L, Lamacchia O, Salvemini L, De Bonis C, De Cosmo S, Cignarelli M, Trischitta V, Menzaghi C


2015; 42(8): 1033-4

Letter: the response to somatostatin analogues in neuroendocrine tumours is influenced by the Ki67 score.

Faggiano A, Carratù AC, Guadagno E, Tafuto S, Tatangelo F, Riccardi F, Mocerino C, Palmieri G, Damiano V, Siciliano R, Leo S, Mauro A, Tozzi LF, Battista C, De Rosa G, Colao A


2015; ():

Papillary thyroid carcinomas with biochemical incomplete or indeterminate responses to initial treatment: repeat stimulated thyroglobulin assay to identify disease-free patients.

Lamartina L, Montesano T, Trulli F, Attard M, Torlontano M, Bruno R, Meringolo D, Monzani F, Tumino S, Ronga G, Maranghi M, Biffoni M, Filetti S, Durante C


2015; 28(10): 1343-59

BRAF V600E and risk stratification of thyroid microcarcinoma: a multicenter pathological and clinical study.

Tallini G, de Biase D, Durante C, Acquaviva G, Bisceglia M, Bruno R, Bacchi Reggiani ML, Casadei GP, Costante G, Cremonini N, Lamartina L, Meringolo D, Nardi F, Pession A, Rhoden KJ, Ronga G, Torlontano M, Verrienti A, Visani M, Filetti S


2015; ():

Adrenalectomy reduces the risk of vertebral fractures in patients with monolateral adrenal incidentalomas and subclinical hypercortisolism.

Salcuni AS, Morelli V, Eller-Vainicher C, Palmieri S, Cairoli E, Spada A, Scillitani A, Chiodini I


2015; 351(): h5868

More on the use of bisphosphonates in the prevention and treatment of osteoporosis.

Minisola S, Cipriani C, Scillitani A, Pepe J


2015; 38(11): 1239-41

A reappraisal of vitamin D effect on non-skeletal targets and mortality.

Minisola S, Cipriani C, Cilli M, Scillitani A, Pepe J


2015; 174(1): D1-8

Imaging of the parathyroid glands in primary hyperparathyroidism.

Minisola S, Cipriani C, Diacinti D, Tartaglia F, Scillitani A, Pepe J, Scott-Coombes D


2015; 100(9): 3231-44

Conventional and Nuclear Medicine Imaging in Ectopic Cushing's Syndrome: A Systematic Review.

Isidori AM, Sbardella E, Zatelli MC, Boschetti M, Vitale G, Colao A, Pivonello R, ABC Study Group


2015; 38(5): 577-93

Italian Society of Endocrinology Consensus Statement: definition, evaluation and management of patients with mild primary hyperparathyroidism.

Marcocci C, Brandi ML, Scillitani A, Corbetta S, Faggiano A, Gianotti L, Migliaccio S, Minisola S


2015; 26(5): 1661-2

Cortisol and the muscle-bone axis: response to comments by Molfino et al.

Scillitani A, Mazziotti G, Di Somma C, Moretti S, Stigliano A, Pivonello R, Giustina A, Colao A, ABC 2011


2015; 100(4): 1309-15

Prevalence of kidney stones and vertebral fractures in primary hyperparathyroidism using imaging technology.

Cipriani C, Biamonte F, Costa AG, Zhang C, Biondi P, Diacinti D, Pepe J, Piemonte S, Scillitani A, Minisola S, Bilezikian JP


2015; 33(1): 44-60

The hypertension of Cushing's syndrome: controversies in the pathophysiology and focus on cardiovascular complications.

Isidori AM, Graziadio C, Paragliola RM, Cozzolino A, Ambrogio AG, Colao A, Corsello SM, Pivonello R, ABC Study Group


2015; ():

A genetic marker of hyperuricemia predicts cardiovascular events in a meta-analysis of three cohort studies in high risk patients.

Testa A, Prudente S, Leonardis D, Spoto B, Sanguedolce MC, Parlongo RM, Tripepi G, Rizza S, Mallamaci F, Federici M, Trischitta V, Zoccali C


2015; 43: 1108–1111

The TRIB3 Q84R polymorphism, insulin resistance and related metabolic alterations

Prudente S., Trischitta V.


2015; 10(10): e0140631

Serum Adiponectin and Glomerular Filtration Rate in Patients with Type 2 Diabetes.

Ortega Moreno L, Lamacchia O, Copetti M, Salvemini L, De Bonis C, De Cosmo S, Cignarelli M, Trischitta V, Menzaghi C


2015; 58 (Suppl 1): S542

Serum adiponectin and glomerular filtration rate in patients with type 2 diabetes

Ortega Moreno L., Lamacchia O., Salvemini L., De Cosmo S., Cignarelli M., Trischitta V., Menzaghi C.

G It Diabetol Metab 2015 2015; 35: 239-246

Ipoglicemia nel paziente diabetico anziano fragile

Rauseo A., Pacilli A., Viti R., Palena A., Bacci S., D'Amico G., Annese M.A., Piscitelli P., Greco A., De Cosmo S.

2015; ():

Serum Uric Acid and Risk of CKD in Type 2 Diabetes.

De Cosmo S, Viazzi F, Pacilli A, Giorda C, Ceriello A, Gentile S, Russo G, Rossi MC, Nicolucci A, Guida P, Feig D, Johnson RJ, Pontremoli R, AMD-Annals Study Group


2015; ():

Strong evidence of sexual dimorphic effect of adiposity excess on insulin sensitivity.

Marucci A, Menzaghi C, Copetti M, Vinciguerra F, Baratta R, Salvemini L, Morini E, Frittitta L, Di Paola R, Trischitta V


2015; 242(1): 334-9

Infrequent TRIB3 coding variants and coronary artery disease in type 2 diabetes.

Prudente S, Bailetti D, Mendonca C, Mannino GC, Fontana A, Andreozzi F, Hastings T, Mercuri L, Alberico F, Basile G, Copetti M, Sesti G, Doria A, Trischitta V


2015; ():

GALNT2 mRNA levels are associated with serum triglycerides in humans.

Marucci A, Mangiacotti D, Trischitta V, Di Paola R


2015; 10(8): e0135855

Identification and Clinical Characterization of Adult Patients with Multigenerational Diabetes Mellitus.

Ludovico O, Carella M, Bisceglia L, Basile G, Mastroianno S, Palena A, De Cosmo S, Copetti M, Prudente S, Trischitta V


2015; ():

TERT Promoter Mutations in Papillary Thyroid Microcarcinomas.

de Biase D, Gandolfi G, Ragazzi M, Eszlinger M, Sancisi V, Gugnoni M, Visani M, Pession A, Casadei G, Durante C, Costante G, Bruno R, Torlontano M, Paschke R, Filetti S, Piana S, Frasoldati A, Tallini G, Ciarrocchi A


2015; 64(1): A114

Comparison of clinical features and mortality rate of adult patients with mutigenerational diabetes and patients with type 2 diabetes

Ludovico O., Carella M., Bisceglia L., Basile G., Mastroianno S., Palena A., Copetti M., De Cosmo S., Prudente S., Trischitta V.

2015; ():

Loss-of-Function Mutations in APPL1 in Familial Diabetes Mellitus.

Prudente S, Jungtrakoon P, Marucci A, Ludovico O, Buranasupkajorn P, Mazza T, Hastings T, Milano T, Morini E, Mercuri L, Bailetti D, Mendonca C, Alberico F, Basile G, Romani M, Miccinilli E, Pizzuti A, Carella M, Barbetti F, Pascarella S, Marchetti P, Tri


2015; ():

Genetic variant at the GLUL locus predicts all-cause mortality in patients with type 2 diabetes.

Prudente S, Shah H, Bailetti D, Pezzolesi M, Buranasupkajorn P, Mercuri L, Mendonca C, De Cosmo S, Niewczas M, Trischitta V, Doria A


2015; ():

Chronic inflammation in offspring of patients with type 2 diabetes and albuminuria.

De Matthaeis A, Di Lorenzo A, Gargano A, Vendemiale G, Bacci S, De Cosmo S


2015; (): 1-8

Achievement of therapeutic targets in patients with diabetes and chronic kidney disease: insights from the Associazione Medici Diabetologi Annals initiative.

De Cosmo S, Viazzi F, Pacilli A, Giorda C, Ceriello A, Gentile S, Russo G, Rossi MC, Nicolucci A, Guida P, Di Bartolo P, Pontremoli R, AMD-Annals Study Group


2015; 10(4): e0124536

Target values of cardiovascular risk factors are not associated with all-cause mortality in patients with type 2 diabetes mellitus.

Pacilli A, Lamacchia O, Fontana A, Copetti M, Cignarelli M, Trischitta V, De Cosmo S


2015; 10(3): e0120419

Association between Resistin Levels and All-Cause and Cardiovascular Mortality: A New Study and a Systematic Review and Meta-Analysis.

Fontana A, Spadaro S, Copetti M, Spoto B, Salvemini L, Pizzini P, Frittitta L, Mallamaci F, Pellegrini F, Trischitta V, Menzaghi C


2015; 10(3): e0119529

Serum resistin and glomerular filtration rate in patients with type 2 diabetes.

Ortega Moreno L, Salvemini L, Mendonca C, Copetti M, De Bonis C, De Cosmo S, Doria A, Trischitta V, Menzaghi C


2015; 313(9): 926-935

The Natural History of Benign Thyroid Nodules.

Durante C, Costante G, Lucisano G, Bruno R, Meringolo D, Paciaroni A, Puxeddu E, Torlontano M, Tumino S, Attard M, Lamartina L, Nicolucci A, Filetti S


2015; ():

Improving adherence to and persistence with oral therapy of osteoporosis.

Bianchi ML, Duca P, Vai S, Guglielmi G, Viti R, Battista C, Scillitani A, Muscarella S, Luisetto G, Camozzi V, Nuti R, Caffarelli C, Gonnelli S, Albanese C, De Tullio V, Isaia G, D'Amelio P, Broggi F, Croci M


2014; :

Tumour-associated fibroblasts contribute to neoangiogenesis in human parathyroid neoplasia

Verdelli C., Avagliano L. , Creo P., Guarnieri V. , Scillitani A ., Vicentini L . , Steffano G.B., Beretta E. , Soldati L., Costa E., Spada A., Bulfamante G.P. and Corbetta S.


2014; ():

Sex-specific effect of BMI on insulin sensitivity and TNF-? expression.

Marucci A, Mangiacotti D, di Mauro L, Antonacci M, Trischitta V, Di Paola R


2014; 57: S149

Insulin signalling genes exert a combined effect on all-cause mortality

Menzaghi C., Fontana A., Copetti M., Rizza S., Spoto B., Tripepi G., Marucci A., Testa A., Mallamaci F., De Cosmo S., Bacci S., Federici M., Zoccali C., Trischitta V.

2014; 63: A417

Insulin Signaling Genes Exert a Combined Effect on All-Cause

Menzaghi C., Bacci S., Fontana A., Rizza S., Spoto B., Tripepi G., Marucci A., Testa A., Copetti M., Mallamaci F., De Cosmo S., Federici M., Zoccali C., Trischitta V.

2014; 63: A349

Circulating Resistin Levels and Mortality Risk

Fontana A., Spadaro S., Marucci A., Salvemini L., Copetti M., Frittitta L., Bacci S., Pellegrini F., Trischitta V., Menzaghi C.

2014; 99(3): 827-34

Long-term follow-up in adrenal incidentalomas: an Italian multicenter study.

Morelli V, Reimondo G, Giordano R, Della Casa S, Policola C, Palmieri S, Salcuni AS, Dolci A, Mendola M, Arosio M, Ambrosi B, Scillitani A, Ghigo E, Beck-Peccoz P, Terzolo M, Chiodini I


2014; (): jc20142857

Increased prevalence of the GCM2 polymorphism, Y282D, in primary hyperparathyroidism: analysis of three Italian cohorts.

D'Agruma L, Coco M, Guarnieri V, Battista C, Canaff L, Salcuni AS, Corbetta S, Cetani F, Minisola S, Chiodini I, Eller-Vainicher C, Spada A, Marcocci C, Guglielmi G, Zini M, Clemente R, Wong BY, de Martino D, Scillitani A, Hendy GN, Cole DE


2014; 37(12): e258-60

Low Prevalence of HNF1A Mutations After Molecular Screening of Multiple MODY Genes in 58 Italian Families Recruited in the Pediatric or Adult Diabetes Clinic From a Single Italian Hospital.

Delvecchio M, Ludovico O, Menzaghi C, Di Paola R, Zelante L, Marucci A, Grasso V, Trischitta V, Carella M, Barbetti F


2014; 37(5): 413-4

Hypovitaminosis D in primary hyperparathyroidism: to treat or not to treat? That is the question.

Minisola S, Romagnoli E, Scillitani A, Rao SD


2014; 25(10): 2499-500

Vitamin D: is evidence of absence, absence of evidence?

Minisola S, Pepe J, Cipriani C, Scillitani A, Piemonte S


2014; 37(10): 1015-6

Vitamin D: not all is bad.

Minisola S, Cipriani C, Piemonte S, Scillitani A, Pepe J


BMC ENDOCRINE DISORDERS 2014; 14(1): 81

A novel mutation in calcium-sensing receptor gene associated to hypercalcemia and hypercalciuria.

Mastromatteo E, Lamacchia O, Campo MR, Conserva A, Baorda F, Cinque L, Guarnieri V, Scillitani A, Cignarelli M


2014; 40(): 58

Clinical heterogeneity of abnormal glucose homeostasis associated with the HNF4A R311H mutation.

Delvecchio M, Di Paola R, Mangiacotti D, Sacco M, Menzaghi C, Trischitta V


2014; : 639-644

Joint effect of insulin signaling genes on all-cause mortality

Menzaghi c., fontana A., Copetti M., rizza S., Spoto B., Buranasupkajorn P., Tripepi G., marucci A., Bailetti D., Hastings T., Testa A., Mendoca C., Mallamaci F., De Cosmo S., Bacci S., Federici M., Doria A., Zoccali C., Trischitta V.

2014; 13(1): 130

Circulating adiponectin and cardiovascular mortality in patients with type 2 diabetes mellitus: evidence of sexual dimorphism.

Menzaghi C, Xu M, Salvemini L, De Bonis C, Palladino G, Huang T, Copetti M, Zheng Y, Li Y, Fini G, Hu FB, Bacci S, Qi L, Trischitta V


2014; 63 (S1): 136 OR

Mutations in the APPL1 Gene May Contribute to Familial Diabetes

Prudente S., Prapaporn J., Marucci A., Ludovico O., Mazza T., Hastings T., Morini E., Mercuri L., Bailetti D., Mendonca C., Alberico F., Basile G., Romani M., Miccinilli E., Carella M., Barbetti F., Trischitta V., Di Paola R., Doria A..

2014; 63 (S1): A421

1614P - The IRS1 G972R Polymorphism Is Associated with Failure to Oral Hypoglycemic Agents in Patients with Type 2 Diabetes

Prudente S., Morini E., Lucchesi D., Lamacchia O., Bailetti D., Mercuri L., Alberico F., Copetti M., Pucci L., Fariello S., Giusti L., Cignarelli M., Penno G., De Cosmo S., Trischitta V.

2014; 57: S154

Mutations in APPL1 gene may contribute to familial diabetes mellitus

Prudente S., Prapaporn J., Marucci A., Ludovico O., Mazza T., Hastings T., Mercuri L., Bailetti D., Mendonca C., Carella M., Barbetti F., Trischitta V., Di Paola R., Doria A.

2014; 63(9): 3135-40

IRS1 G972R missense polymorphism is associated with failure to oral antidiabetes drugs in white patients with type 2 diabetes from Italy.

Prudente S, Morini E, Lucchesi D, Lamacchia O, Bailetti D, Mercuri L, Alberico F, Copetti M, Pucci L, Fariello S, Giusti L, Cignarelli M, Penno G, De Cosmo S, Trischitta V


2014; ():

Carotid intima-media thickness is not associated with vitamin D and PTH levels in patients admitted to an Internal Medicine Department.

Carnevale V, Minonne R, De Matthaeis A, Annese MA, Tabacco P, D'Arcangelo P, D'Amico G, Scillitani A


2014; ():

Estimate of body composition by Hume's equation: validation with DXA.

Carnevale V, Piscitelli PA, Minonne R, Castriotta V, Cipriani C, Guglielmi G, Scillitani A, Romagnoli E


2014; 24(7): 1139-45

Clinical aggressiveness and long-term outcome in patients with papillary thyroid cancer and circulating anti-thyroglobulin autoantibodies.

Durante C, Tognini S, Montesano T, Orlandi F, Torlontano M, Puxeddu E, Attard M, Costante G, Tumino S, Meringolo D, Bruno R, Trulli F, Toteda M, Redler A, Ronga G, Filetti S, Monzani F, PTC Study Group


2014; 37(4): 281-8

A novel CDC73 gene mutation in an Italian family with hyperparathyroidism-jaw tumour (HPT-JT) syndrome.

Chiofalo MG, Sparaneo A, Chetta M, Franco R, Baorda F, Cinque L, Granatiero M, D'Agruma L, Pezzullo L, Scillitani A, Guarnieri V


2014; ():

Risk of nephrolithiasis in primary hyperparathyroidism is associated with two polymorphisms of the calcium-sensing receptor gene.

Vezzoli G, Scillitani A, Corbetta S, Terranegra A, Dogliotti E, Guarnieri V, Arcidiacono T, Macrina L, Mingione A, Brasacchio C, Eller-Vainicher C, Cusi D, Spada A, Cole DE, Hendy GN, Spotti D, Soldati L


2014; 171(3): 399-406

Factors associated with vertebral fracture risk in patients with primary hyperparathyroidism.

Eller-Vainicher C, Battista C, Guarnieri V, Muscarella S, Palmieri S, Salcuni AS, Guglielmi G, Corbetta S, Minisola S, Spada A, Hendy GN, Cole DE, Chiodini I, Scillitani A


2014; 29(3): 657-62

Kidney dysfunction and related cardiovascular risk factors among patients with type 2 diabetes.

De Cosmo S, Rossi MC, Pellegrini F, Lucisano G, Bacci S, Gentile S, Ceriello A, Russo G, Nicolucci A, Giorda C, Viazzi F, Pontremoli R, AMD-Annals Study Group


2014; ():

Normoalbuminuric renal impairment and all-cause mortality in type 2 diabetes mellitus.

De Cosmo S, Lamacchia O, Pacilli A, Fariello S, Pinnelli S, Fontana A, Di Mauro L, Cignarelli M, Trischitta V


2013; 36(9): 2830-5

Development and validation of a predicting model of all-cause mortality in patients with type 2 diabetes.

De Cosmo S, Copetti M, Lamacchia O, Fontana A, Massa M, Morini E, Pacilli A, Fariello S, Palena A, Rauseo A, Viti R, Di Paola R, Menzaghi C, Cignarelli M, Pellegrini F, Trischitta V


2013; 73(1): 50-8

Molecular Dissection of the VHL Gene in Solitary Capillary Hemangioblastoma of the Central Nervous System.

Muscarella LA, la Torre A, Faienza A, Catapano D, Bisceglia M, D'Angelo V, Parrella P, Coco M, Fini G, Tancredi A, Zelante L, Fazio VM, D'Agruma L


2013; 8(12): e82292

Identification and Functional Characterization of Three NoLS (Nucleolar Localisation Signals) Mutations of the CDC73 Gene

Pazienza V, la Torre A, Baorda F, Alfarano M, Chetta M, Muscarella LA, Battista C, Copetti M, Kotzot D, Kapelari K, Al-Abdulrazzaq D, Perlman K, Sochett E, Cole DE, Pellegrini F, Canaff L, Hendy GN, D'Agruma L, Zelante L, Carella M, Scillitani A, Guarnier


2013; 169(2): 155-62

Bone quality, as measured by trabecular bone score, in patients with primary hyperparathyroidism.

Eller-Vainicher C, Filopanti M, Palmieri S, Ulivieri FM, Morelli V, Zhukouskaya VV, Cairoli E, Pino R, Naccarato A, Verga U, Scillitani A, Beck-Peccoz P, Chiodini I


2013; ():

GH secretion reserve in subclinical hypercortisolism.

Palmieri S, Morelli V, Salcuni AS, Eller-Vainicher C, Cairoli E, Zhukouskaya VV, Beck-Peccoz P, Scillitani A, Chiodini I


2013; ():

Treatment of skeletal impairment in patients with endogenous hypercortisolism: when and how?

Scillitani A, Mazziotti G, Di Somma C, Moretti S, Stigliano A, Pivonello R, Giustina A, Colao A, On behalf of ABC Group


2013; 169(2): 225-37

Prevalence of subclinical contributors to low bone mineral density and/or fragility fracture.

Eller-Vainicher C, Cairoli E, Zhukouskaya VV, Morelli V, Palmieri S, Scillitani A, Beck-Peccoz P, Chiodini I


HORMONES 2013 2013; 12(4): 1-4

Over-supplementation of vitamin D in two patients with primary hyperparathyroidism

Battista C., Viti R., Minisola S., Chiodini I., Frusciante V., Scillitani A., Carnevale V.

2013; 23(11): 1043-9

The SH2B1 obesity locus and abnormal glucose homeostasis: Lack of evidence for association from a meta-analysis in individuals of European ancestry.

Prudente S, Copetti M, Morini E, Mendonca C, Andreozzi F, Chandalia M, Baratta R, DIAGRAM consortium, Pellegrini F, Mercuri L, Bailetti D, Abate N, Frittitta L, Sesti G, Florez JC, Doria A, Trischitta V


2013; 56: S536

Evidence for sex-specific effect of serum total adiponectin on cardiovascular death in patients with type 2 diabetes mellitus

Menzaghi C., Xu M., Salvemini L., De Bonis C., Fini G., Palladino G., Bacci S., Qi L., Trischitta V.

2013; 5: S172

Evidence of reverse epidemiology between obesity and all-cause mortality in whites with type 2 diabetes from Italy

Di Paola R., Marucci A., Fontana A., Menzaghi C., Salvemini L., Copetti M., Pellegrini F., De Cosmo S., Trischitta V.

Società Italiana di Genetica Umana - XVI Congresso Nazionale 2013; : P279

Raro caso di sincrona insorgenza di carcinoma delle paratiroidi e delle vie biliari extraepatiche (coledoco): analisi di CNV rivela nuovi possibili geni coinvolti nella tumorigenesi delle due diverse patologie

Palumbo O., Salcuni A.S., Clemente C., Caruso N., Battista C., Di Candia L. , Bisceglia M., Maiello E., Scillitani A., Guarnieri V.

Società Italiana di Genetica Umana - XVI Congresso Nazionale 2013; : P131

Screening negativo dei geni CASR, GNA11 e AP2S1 in una coorte di pazienti affetti da ipercalcemia ipocalciurica familiare (FHH): c’è posto per un altro gene?

Guarnieri V., Palladino T., Leone M.P., Baorda F., Battista C., Salcuni A.S., D'Agruma L., Cole D.E., Hendy G.N., Scillitani A.

2013; 28(12): 3031-4

The IRS1 G972R polymorphism and glomerular filtration rate in patients with type 2 diabetes of European ancestry.

De Cosmo S, Prudente S, Lamacchia O, Pucci L, Lucchesi D, Mendonca C, Bailetti D, Copetti M, Pellegrini F, Cignarelli M, Penno G, Doria A, Trischitta V


2013; ():

Role of obesity on all-cause mortality in whites with type 2 diabetes from Italy.

Di Paola R, Marucci A, Fontana A, Menzaghi C, Salvemini L, Copetti M, Pellegrini F, De Cosmo S, Trischitta V


2013; 98(6): E1143-7

Joint effect of insulin signaling genes on insulin secretion and glucose homeostasis.

Prudente S, Morini E, Marselli L, Baratta R, Copetti M, Mendonca C, Andreozzi F, Chandalia M, Pellegrini F, Bailetti D, Alberico F, Shah H, Abate N, Sesti G, Frittitta L, Marchetti P, Doria A, Trischitta V


2013; 310(8): 821-8

Association between a genetic variant related to glutamic acid metabolism and coronary heart disease in individuals with type 2 diabetes.

Qi L, Qi Q, Prudente S, Mendonca C, Andreozzi F, di Pietro N, Sturma M, Novelli V, Mannino GC, Formoso G, Gervino EV, Hauser TH, Muehlschlegel JD, Niewczas MA, Krolewski AS, Biolo G, Pandolfi A, Rimm E, Sesti G, Trischitta V, Hu F, Doria A


2013; 8(7): e70159

GALNT2 Expression Is Reduced in Patients with Type 2 Diabetes: Possible Role of Hyperglycemia.

Marucci A, di Mauro L, Menzaghi C, Prudente S, Mangiacotti D, Fini G, Lotti G, Trischitta V, Di Paola R


2013; 228(1): 247-8

Role of relationship between HbA1c, fibrinogen and HDL-cholesterol on cardiovascular disease in patients with type 2 diabetes mellitus.

Pacilli A, De Cosmo S, Trischitta V, Bacci S


2013; 8(6): e64729

Serum resistin, cardiovascular disease and all-cause mortality in patients with type 2 diabetes.

Menzaghi C, Bacci S, Salvemini L, Mendonca C, Palladino G, Fontana A, De Bonis C, Marucci A, Goheen E, Prudente S, Morini E, Rizza S, Kanagaki A, Fini G, Mangiacotti D, Federici M, De Cosmo S, Pellegrini F, Doria A, Trischitta V


2013; 1833(6): 1388-95

Role of GALNT2 in the modulation of ENPP1 expression, and insulin signaling and action: GALNT2: a novel modulator of insulin signaling.

Marucci A, Cozzolino F, Dimatteo C, Monti M, Pucci P, Trischitta V, Di Paola R


2013; :

Development and validation of a predicting model of all-cause mortality in patients with type 2 diabetes mellitus

De Cosmo S, Copetti M, Lamacchia O, Fontana A, Michela M, Morini E, Pacilli A, Fariello S, Palena A, Rauseo A, Viti R, Di Paola R, Menzaghi C, Cignarelli M, Pellegrini F, Trischitta V,

2013; 98(2): 636-42

Papillary thyroid cancer: time course of recurrences during postsurgery surveillance.

Durante C, Montesano T, Torlontano M, Attard M, Monzani F, Tumino S, Costante G, Meringolo D, Bruno R, Trulli F, Massa M, Maniglia A, D'Apollo R, Giacomelli L, Ronga G, Filetti S, PTC Study Group


Giorn. It. Ost. Gin. Vol XXXIV- n.4 2012; :

Impatto dei fattori ostetrici sulla donazione del sangue cordonale: due anni di attività

Volpe G., Miscio G., Santodirocco M., di Mauro L., Boscia F.M., Sparviero S., Caradonna G., carbotta A.M., Casulli S., Lovascio G., Labianca L., De Palma E., Sangiorgio G., Latrofa R., Savino A., Di Cecca M., Locorotondo V., Damiani L., Partipilo V., Camp

2012; 22(11): 997-1006

Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: impact on cardiovascular events. A randomized controlled trial.

Vaccaro O, Masulli M, Bonora E, Del Prato S, Giorda CB, Maggioni AP, Mocarelli P, Nicolucci A, Rivellese AA, Squatrito S, Riccardi G, TOSCA.IT study group (Thiazolidinediones Or Sulphonylureas and Cardiovascular Accidents. Intervention Trial)


Osteoporosi.it - XII Congresso Nazionale SIOMMMS 2012; Bologna, 15/17 novembre 2012: 3-4

Osteomalacia oncogenica: utilità della PET/TC con 18-F-Fluoro-Desossiglucosio

Scillitani A, Perrone E, Simeone A, Viti R, Battista C, Bisceglia M, Carnevale V, Valle G

2012; 35(7 Suppl): 2-21

AME position statement: primary hyperparathyroidism in clinical practice.

Zini M, Attanasio R, Cesareo R, Emmolo I, Frasoldati A, Gianotti L, Guglielmi R, Piovesan A, Procopio M, Scillitani A, Versari A, Bollerslev J, Rao DS, Marcocci C, Borretta G, Italian Association of Clinical Endocrinologists


2012; ():

Effect of Gender and Geographic Location On the Expression of Primary Hyperparathyroidism.

De Lucia F, Minisola S, Romagnoli E, Pepe J, Cipriani C, Scillitani A, Parikh N, Rao DS


2012; 168(2): 235-41

Bilateral and unilateral adrenal incidentalomas: biochemical and clinical characteristics.

Morelli V, Palmieri S, Salcuni AS, Eller-Vainicher C, Cairoli E, Zhukouskaya V, Scillitani A, Beck-Peccoz P, Chiodini I


2012; 97(10): 3467-75

Screening of Cushing's syndrome in outpatients with type 2 diabetes: results of a prospective multicentric study in Italy.

Terzolo M, Reimondo G, Chiodini I, Castello R, Giordano R, Ciccarelli E, Limone P, Crivellaro C, Martinelli I, Montini M, Disoteo O, Ambrosi B, Lanzi R, Arosio M, Senni S, Balestrieri A, Solaroli E, Madeo B, De Giovanni R, Strollo F, Battista R, Scorsone


2012; ():

Cinacalcet in the management of primary hyperparathyroidism: post marketing experience of an Italian multicentre group.

Saponaro F, Faggiano A, Grimaldi F, Borretta G, Brandi ML, Minisola S, Frasoldati A, Papini E, Scillitani A, Banti C, Del Prete M, Vescini F, Gianotti L, Cavalli L, Romagnoli E, Colao A, Cetani F, Marcocci C


2012; 27(10): 2223-30

Bone quality, as measured by trabecular bone score in patients with adrenal incidentalomas with and without subclinical hypercortisolism.

Eller-Vainicher C, Morelli V, Ulivieri FM, Palmieri S, Zhukouskaya VV, Cairoli E, Pino R, Naccarato A, Scillitani A, Beck-Peccoz P, Chiodini I


2012; 83(1): 83-7

MODY type 2 P59S GCK mutant: founder effect in South of Italy.

Delvecchio M, Ludovico O, Bellacchio E, Stallone R, Palladino T, Mastroianno S, Zelante L, Sacco M, Trischitta V, Carella M


2012; 21(21): 4774-80

Genome-wide association analysis identifies TYW3/CRYZ and NDST4 loci associated with circulating resistin levels.

Qi Q, Menzaghi C, Smith S, Liang L, de Rekeneire N, Garcia ME, Lohman KK, Miljkovic I, Strotmeyer ES, Cummings SR, Kanaya AM, Tylavsky FA, Satterfield S, Ding J, Rimm EB, Trischitta V, Hu FB, Liu Y, Qi L


2012; 97(8): 2748-53

Long-term surveillance of papillary thyroid cancer patients who do not undergo postoperative radioiodine remnant ablation: is there a role for serum thyroglobulin measurement?

Durante C, Montesano T, Attard M, Torlontano M, Monzani F, Costante G, Meringolo D, Ferdeghini M, Tumino S, Lamartina L, Paciaroni A, Massa M, Giacomelli L, Ronga G, Filetti S, PTC Study Group


2012; ():

Role of somatomedin-B-like domains on ENPP1 inhibition of insulin signaling.

Dimatteo C, Marucci A, Palazzo A, Cisternino C, Marsano RM, Trischitta V, Di Paola R


2012; 226(1): 140-5

Joint effect of insulin signaling genes on cardiovascular events and on whole body and endothelial insulin resistance.

Bacci S, Prudente S, Copetti M, Spoto B, Rizza S, Baratta R, Di Pietro N, Morini E, Di Paola R, Testa A, Mallamaci F, Tripepi G, Zhang YY, Mercuri L, Di Silvestre S, Lauro R, Malatino L, Consoli A, Pellegrini F, Pandolfi A, Frittitta L, Zoccali C, Federic


2012; 35(6): 411-22

CDC73 mutations and parafibromin immunohistochemistry in parathyroid tumors: clinical correlations in a single-centre patient cohort.

Guarnieri V, Battista C, Muscarella LA, Bisceglia M, de Martino D, Baorda F, Maiello E, D'Agruma L, Chiodini I, Clemente C, Minisola S, Romagnoli E, Corbetta S, Viti R, Eller-Vainicher C, Spada A, Iacobellis M, Malavolta N, Carella M, Canaff L, Hendy GN,


2012; 22(11): 929-36

Genetic prediction of common diseases. Still no help for the clinical diabetologist!

Prudente S, Dallapiccola B, Pellegrini F, Doria A, Trischitta V


2012; 33(4): 526-46

The mammalian tribbles homolog TRIB3, glucose homeostasis, and cardiovascular diseases.

Prudente S, Sesti G, Pandolfi A, Andreozzi F, Consoli A, Trischitta V


2012; ():

Role of insulin resistance in kidney dysfunction: insights into the mechanism and epidemiological evidence.

De Cosmo S, Menzaghi C, Prudente S, Trischitta V


2012; 27(12): 4411-3

The 9p21 coronary artery disease locus and kidney dysfunction in patients with Type 2 diabetes mellitus.

De Cosmo S, Prudente S, Lamacchia O, Lucchesi D, Shah H, Mendonca C, Pucci L, Mercuri L, Gervino EV, Hauser TH, Bailetti D, Penno G, Cignarelli M, Doria A, Trischitta V


2012; 27(10): 2217-22

Bone involvement in aldosteronism.

Salcuni AS, Palmieri S, Carnevale V, Morelli V, Battista C, Guarnieri V, Guglielmi G, Desina G, Eller-Vainicher C, Beck-Peccoz P, Scillitani A, Chiodini I


2012; 107(3): 548-52

CASR gene activating mutations in two families with autosomal dominant hypocalcemia.

Guarnieri V, Valentina D'Elia A, Baorda F, Pazienza V, Benegiamo G, Stanziale P, Copetti M, Battista C, Grimaldi F, Damante G, Pellegrini F, D'Agruma L, Zelante L, Carella M, Scillitani A


2012; ():

The ectonucleotide pyrophosphatase phosphodiesterase 1 (ENPP1) K121Q polymorphism modulates the beneficial effect of weight loss on fasting glucose in non-diabetic individuals.

Maranghi M, Prudente S, D'Erasmo L, Morini E, Ciociola E, Coletta P, Verrienti A, Arciello S, Copetti M, Pellegrini F, Santini SA, Morano S, Filetti S, Trischitta V


Congresso Hot Topics in Cardionefrologia 2012; San Severo: 27-28/04/2012

Prevenzione e terapia della Nefropatia diabetica: nuove evidenze

De Cosmo S

2012; 49(2): 115-124

The microRNA cluster C19MC is deregulated in parathyroid tumours.

Vaira V, Elli F, Forno I, Guarnieri V, Verdelli C, Ferrero S, Scillitani A, Vicentini L, Cetani F, Mantovani G, Spada A, Bosari S, Corbetta S


2012; 7(6): e38414

Serum resistin and kidney function: a family-based study in non-diabetic, untreated individuals.

Menzaghi C, Salvemini L, Fini G, Thompson R, Mangiacotti D, Di Paola R, Morini E, Giorelli M, De Bonis C, De Cosmo S, Doria A, Trischitta V


2011; 29(10): 1994-2003

Inappropriately high left ventricular mass in patients with type 2 diabetes mellitus and no overt cardiac disease. The DYDA study.

Cioffi G, Faggiano P, Lucci D, Di Lenarda A, Mureddu GF, Tarantini L, Verdecchia P, Comaschi M, Giorda CB, Velussi M, Chinali M, Latini R, Masson S, De Simone G, DYDA Investigators


2011; 34(7 Suppl): 23-6

Carboxyl-terminal parathyroid hormone fragments: biologic effects.

Scillitani A, Guarnieri V, Battista C, Chiodini I, Salcuni AS, Minisola S, Francucci CM, Carnevale V


XIV Congresso Nazionale della Società Italiana di Genetica Umana 2011; SIGU: cod. 170

Ruolo dei Polimorfismi funzionali nel gene CASR nella malattia di Alzheimer sporadica

Guarnieri V, Paroni G, Bizzarro A, Gravina C, Nocco A, Baorda F, Urbano M, Daniele A, Scillitani A, Logroscino G, Masullo C, Greco A

XIV Congresso Nazionale della Società Italiana di Genetica Umana 2011; SIGU: cod. 169

Nuove mutazioni del gene CASR in pazienti affetti da FHH, ADH e PHPT

Guarnieri V, Baorda F, Stanziale P, Battista C, Procino G, Stratta P, D'Elia AV, Damante G, Romagnoli E, Minisola S, D'Agruma L, Carella M

2011; 164(3): 421-7

Polymorphisms at the regulatory regions of the CASR gene influence stone risk in primary hyperparathyroidism.

Vezzoli G, Scillitani A, Corbetta S, Terranegra A, Dogliotti E, Guarnieri V, Arcidiacono T, Paloschi V, Rainone F, Eller-Vainicher C, Borghi L, Nouvenne A, Guerra A, Meschi T, Allegri F, Cusi D, Spada A, Cole DE, Hendy GN, Spotti D, Soldati L


2011; 29(9): 1802-9

Clinical significance of nonalbuminuric renal impairment in type 2 diabetes.

Penno G, Solini A, Bonora E, Fondelli C, Orsi E, Zerbini G, Trevisan R, Vedovato M, Gruden G, Cavalot F, Cignarelli M, Laviola L, Morano S, Nicolucci A, Pugliese G, Renal Insufficiency And Cardiovascular Events (RIACE) Study Group


2011; ():

A rare S33C mutation of CTNNB1 encoding ß-catenin in a parathyroid adenoma found in an Italian primary hyperparathyroid cohort.

Guarnieri V, Baorda F, Battista C, Bisceglia M, Balsamo T, Gruppioni E, Fiorentino M, Muscarella LA, Coco M, Barbano R, Corbetta S, Spada A, Cole DE, Canaff L, Hendy GN, Carella M, Scillitani A


Attualità in Diabetologia e Malattie Metaboliche 2011; :

Prevenzione del Diabete Mellito Tipo 2

Del Prato S, Sesti G, Averna M, De Feo P, Trischitta V et al.

2011; ():

Insulin resistance and left ventricular hypertrophy in end-stage renal disease: association between the ENPP1 gene and left ventricular concentric remodelling.

Spoto B, Testa A, Parlongo RM, Tripepi G, Trischitta V, Mallamaci F, Zoccali C


2011; 60(8): 2197-201

Novel locus FER is associated with serum HMW adiponectin levels.

Qi L, Menzaghi C, Salvemini L, De Bonis C, Trischitta V, Hu FB


2011; 31(5): 1343-64

Integrated imaging approach to osteoporosis: state-of-the-art review and update.

Guglielmi G, Muscarella S, Bazzocchi A


Clinical Cases in Mineral and Bone Metabolism 2011; 8(1): 33-36

Oncogenic osteomalacia due to phosphaturic mesenchymal tumor of the craniofacial sinuses

Guglielmi G, Bisceglia M, Scillitani A, Folpe AL

2011; 34(7): 40-44

Sporadic and hereditary primary hyperparathyroidism

Pepe J, Cipriani C, Pilotto R, De Lucia F, Castro C, Lenge L, Russo S, Guarnieri V, Scillitani A, Carnevale V, D'Erasmo E, Romagnoli E, Minisola S


2011; 34(7): 23-26

Carboxyl-terminal parathyroid hormone fragments: Biologic effects

Scillitani A, Guarnieri V, Battista C, Chiodini I, Salcuni AS, Minisola S, Francucci CM, Carnevale V

2011; 216(1): 157-60

The type 2 diabetes and insulin-resistance locus near IRS1 is a determinant of HDL cholesterol and triglycerides levels among diabetic subjects.

Sharma R, Prudente S, Andreozzi F, Powers C, Mannino G, Bacci S, Gervino EV, Hauser TH, Succurro E, Mercuri L, Goheen EH, Shah H, Trischitta V, Sesti G, Doria A


2011; ():

The SH2B1 obesity locus is associated with myocardial infarction in diabetic patients and with NO synthase activity in endothelial cells.

Prudente S, Morini E, Larmon J, Andreozzi F, Di Pietro N, Nigro A, Gervino EV, Mannino GC, Bacci S, Hauser TH, Bellacchio E, Formoso G, Pellegrini F, Proto V, Menzaghi C, Frittitta L, Pandolfi A, Sesti G, Doria A, Trischitta V


2011; ():

ENPP1 mRNA levels in white blood cells and prediction of metformin efficacy in type 2 diabetic patients: A preliminary evidence.

Ludovico O, Farina MG, Copetti M, Palena A, Proto V, Marotta V, Strippoli GF, Frittitta L, Trischitta V, Prudente S


2011; 89(1): 184-92

The TRIB3 R84 variant is associated with increased carotid intima-media thickness in vivo and with enhanced MAPK signalling in human endothelial cells.

Formoso G, Di Tomo P, Andreozzi F, Succurro E, Di Silvestre S, Prudente S, Perticone F, Trischitta V, Sesti G, Pandolfi A, Consoli A


2011; 6(5): e19462

ENPP1 affects insulin action and secretion: evidences from in vitro studies.

Di Paola R, Caporarello N, Marucci A, Dimatteo C, Iadicicco C, Del Guerra S, Prudente S, Sudano D, Miele C, Parrino C, Piro S, Beguinot F, Marchetti P, Trischitta V, Frittitta L


2011; 40(3): 481-5

Coexistence of multiple endocrine neoplasia type 1 and type 2 in a large Italian family.

Mastroianno S, Torlontano M, Scillitani A, D'Aloiso L, Verrienti A, Bonfitto N, De Bonis A, D'Agruma L, Muscarella LA, Guarnieri V, Dicembrino F, Maranghi M, Durante C, Filetti S


2011; 54(s1): 339-340

Genetic predictors of steatosis and fibrosis in non alcoholic fatty liver disease (NAFLD)

Mangia A, Mottola L, Petruzzellis D, Piazzolla V, Garrubba M, Di Paola R, Santoro R, Trischitta V, Villella M, Fanelli R, Vanni E, Seripa D, Pilotto A, Bugianesi E, Guido M, Santini SA

2011; 96(5): 1352-9

Long-term follow-up of patients with papillary and follicular thyroid cancer: a prospective study on 715 patients.

Brassard M, Borget I, Edet-Sanson A, Giraudet AL, Mundler O, Toubeau M, Bonichon F, Borson-Chazot F, Leenhardt L, Schvartz C, Dejax C, Brenot-Rossi I, Toubert ME, Torlontano M, Benhamou E, Schlumberger M, THYRDIAG Working Group


2011; ():

PPAR?2 P12A polymorphism and albuminuria in patients with type 2 diabetes: a meta-analysis of case-control studies.

De Cosmo S, Prudente S, Lamacchia O, Lapice E, Morini E, Di Paola R, Copetti M, Ruggenenti P, Remuzzi G, Vaccaro O, Cignarelli M, Trischitta V


2011; 60(3): 1000-7

The ENPP1 Q121 variant predicts major cardiovascular events in high-risk individuals: evidence for interaction with obesity in diabetic patients.

Bacci S, Rizza S, Prudente S, Spoto B, Powers C, Facciorusso A, Pacilli A, Lauro D, Testa A, Zhang YY, Di Stolfo G, Mallamaci F, Tripepi G, Xu R, Mangiacotti D, Aucella F, Lauro R, Gervino EV, Hauser TH, Copetti M, De Cosmo S, Pellegrini F, Zoccal et al.


2011; 34(2): 347-52

Quality of diabetes care predicts the development of cardiovascular events: results of the AMD-QUASAR study.

Rossi MC, Lucisano G, Comaschi M, Coscelli C, Cucinotta D, Di Blasi P, Bader G, Pellegrini F, Valentini U, Vespasiani G, Nicolucci A, AMD-QUASAR Study Group


2011; 54(4): 812-8

Relationship between ADIPOQ gene, circulating high molecular weight adiponectin and albuminuria in individuals with normal kidney function: evidence from a family-based study.

Menzaghi C, De Cosmo S, Copetti M, Salvemini L, De Bonis C, Mangiacotti D, Fini G, Pellegrini F, Trischitta V


{accordionfaq faqid=accordion3 faqclass="lightnessfaq defaulticon headerbackground headerborder contentbackground contentborder round5" active=0}

nuovo-css

webcamlive

Newsletter

Informativa Newsletter
  twitter   facebook   youtube